150 related articles for article (PubMed ID: 19892591)
1. Acute wrist and foot drop associated with hepatitis C virus related mixed cryoglobulinemia: rapid response to treatment with rituximab.
Uppal R; Charles E; Lake-Bakaar G
J Clin Virol; 2010 Jan; 47(1):69-71. PubMed ID: 19892591
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis.
Roccatello D; Baldovino S; Rossi D; Mansouri M; Naretto C; Gennaro M; Cavallo R; Alpa M; Costanzo P; Giachino O; Mazzucco G; Sena LM
Nephrol Dial Transplant; 2004 Dec; 19(12):3054-61. PubMed ID: 15494358
[TBL] [Abstract][Full Text] [Related]
3. Should rituximab be the rescue therapy for refractory mixed cryoglobulinemia associated with hepatitis C?
Ahmed MS; Wong CF
J Nephrol; 2007; 20(3):350-6. PubMed ID: 17557269
[TBL] [Abstract][Full Text] [Related]
4. Treatment of cryoglobulinemia associated peripheral neuropathy with rituximab.
Cai FZ; Ahern M; Smith M
J Rheumatol; 2006 Jun; 33(6):1197-8. PubMed ID: 16755669
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment.
Roll P; Dörner T; Tony HP
Arthritis Rheum; 2008 Jun; 58(6):1566-75. PubMed ID: 18512772
[TBL] [Abstract][Full Text] [Related]
6. Increased T-cell sinusoidal lymphocytosis in liver biopsies in patients with chronic hepatitis C and mixed cryoglobulinemia.
Carmack S; Taddei T; Robert ME; Mistry P; Jain D
Am J Gastroenterol; 2008 Mar; 103(3):705-11. PubMed ID: 17970837
[TBL] [Abstract][Full Text] [Related]
7. The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders.
Landau DA; Rosenzwajg M; Saadoun D; Klatzmann D; Cacoub P
Ann Rheum Dis; 2009 Mar; 68(3):337-44. PubMed ID: 18434450
[TBL] [Abstract][Full Text] [Related]
8. Rituximab may form a complex with IgMkappa mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis.
Sène D; Ghillani-Dalbin P; Amoura Z; Musset L; Cacoub P
Arthritis Rheum; 2009 Dec; 60(12):3848-55. PubMed ID: 19950292
[TBL] [Abstract][Full Text] [Related]
9. [An autopsy case of systemic vasculitis associated with hepatitis C virus-related mixed cryoglobulinemia presenting severe peripheral neuropathy].
Tada M; Naruse S; Arai A; Sato A; Tanaka K; Piao YS; Kakita A; Takahashi H; Nishizawa M; Tsuji S
Rinsho Shinkeigaku; 2004 Oct; 44(10):686-90. PubMed ID: 15568485
[TBL] [Abstract][Full Text] [Related]
10. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P
Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
[TBL] [Abstract][Full Text] [Related]
11. Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders.
Terrier B; Sène D; Saadoun D; Ghillani-Dalbin P; Thibault V; Delluc A; Piette JC; Cacoub P
Ann Rheum Dis; 2009 Jan; 68(1):89-93. PubMed ID: 18375535
[TBL] [Abstract][Full Text] [Related]
12. Clonal CD27+ CD19+ B cell expansion through inhibition of FC gammaIIR in HCV(+) cryoglobulinemic patients.
De Re V; Pavan A; Sansonno S; Sansonno D; Racanelli V
Ann N Y Acad Sci; 2009 Sep; 1173():326-33. PubMed ID: 19758169
[TBL] [Abstract][Full Text] [Related]
13. [Monoclonal antibodies to B-lymphocytes (rituximab) in the treatment of HCV-associated severe cryoglobulinemic glomerulonephritis].
Milovanova SIu; Lopatkina TN; Kozlovskaia LV; Krasnova TN
Ter Arkh; 2007; 79(6):69-72. PubMed ID: 17684972
[No Abstract] [Full Text] [Related]
14. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy.
Mazzaro C; Franzin F; Tulissi P; Pussini E; Crovatto M; Carniello GS; Efremov DG; Burrone O; Santini G; Pozzato G
Cancer; 1996 Jun; 77(12):2604-13. PubMed ID: 8640712
[TBL] [Abstract][Full Text] [Related]
15. Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma.
Feldmann G; Nischalke HD; Nattermann J; Banas B; Berg T; Teschendorf C; Schmiegel W; Dührsen U; Halangk J; Iwan A; Sauerbruch T; Caselmann WH; Spengler U
Clin Cancer Res; 2006 Aug; 12(15):4491-8. PubMed ID: 16899594
[TBL] [Abstract][Full Text] [Related]
16. In vivo human B-cell subset recovery after in vivo depletion with rituximab, anti-human CD20 monoclonal antibody.
Sidner RA; Book BK; Agarwal A; Bearden CM; Vieira CA; Pescovitz MD
Hum Antibodies; 2004; 13(3):55-62. PubMed ID: 15598985
[TBL] [Abstract][Full Text] [Related]
17. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids.
Quartuccio L; Soardo G; Romano G; Zaja F; Scott CA; De Marchi G; Fabris M; Ferraccioli G; De Vita S
Rheumatology (Oxford); 2006 Jul; 45(7):842-6. PubMed ID: 16418196
[TBL] [Abstract][Full Text] [Related]
18. Mixed cryoglobulinemia in hepatitis C patients. GERMIVIC.
Cacoub P; Hausfater P; Musset L; Piette JC
Ann Med Interne (Paris); 2000 Feb; 151(1):20-9. PubMed ID: 10761559
[TBL] [Abstract][Full Text] [Related]
19. [The extrahepatic site of hepatitis C virus: clinical manifestations and prognostic value].
Krel' PE; Tsinzerling OD
Ter Arkh; 2009; 81(11):63-8. PubMed ID: 20141018
[TBL] [Abstract][Full Text] [Related]
20. B-cells and mixed cryoglobulinemia.
Ferri C; Antonelli A; Mascia MT; Sebastiani M; Fallahi P; Ferrari D; Giunti M; Pileri SA; Zignego AL
Autoimmun Rev; 2007 Dec; 7(2):114-20. PubMed ID: 18035320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]